Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 443

Similar articles for PubMed (Select 11007221)

1.

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.

Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH.

Am J Gastroenterol. 2000 Sep;95(9):2218-24.

PMID:
11007221
2.

Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.

Miyake K, Akimoto T, Hanada Y, Nagoya H, Kodaka Y, Ueki N, Kusunoki M, Kawagoe T, Futagami S, Takahashi Y, Takano H, Sakamoto C.

Dig Liver Dis. 2015 Jun 2. pii: S1590-8658(15)00349-7. doi: 10.1016/j.dld.2015.05.020. [Epub ahead of print]

PMID:
26105589
3.

Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-Inflammatory Drugs, Antiplatelet Agents, or Anticoagulants.

Palmer RH.

Clin Gastroenterol Hepatol. 2015 May 28. pii: S1542-3565(15)00704-1. doi: 10.1016/j.cgh.2015.05.025. [Epub ahead of print] No abstract available.

PMID:
26027546
4.

Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

Lanas Á, Carrera-Lasfuentes P, Arguedas Y, García S, Bujanda L, Calvet X, Ponce J, Perez-Aísa Á, Castro M, Muñoz M, Sostres C, García-Rodríguez LA.

Clin Gastroenterol Hepatol. 2015 May;13(5):906-12.e2. doi: 10.1016/j.cgh.2014.11.007. Epub 2014 Nov 14.

PMID:
25460554
5.

Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.

Thorat MA, Cuzick J.

Eur J Epidemiol. 2015 Jan;30(1):5-18. doi: 10.1007/s10654-014-9971-7. Epub 2014 Nov 25. Review.

PMID:
25421783
6.

Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis.

Li H, Cheng Y, Ahl J, Skljarevski V.

Drug Healthc Patient Saf. 2014 Oct 29;6:167-74. doi: 10.2147/DHPS.S66835. eCollection 2014.

7.

Can we improve the efficacy of low-dose aspirin?

Grove EL, Storey RF, Kristensen SD.

Thromb Haemost. 2014 Dec;112(6):1077-8. doi: 10.1160/TH14-08-0702. Epub 2014 Sep 11. No abstract available.

PMID:
25208629
8.

[Enteric-coated aspirin does not reduce the risk of gastrointestinal side effects.]

Haastrup P, Jarbøl DE.

Ugeskr Laeger. 2014 Apr 28;176(9). pii: V09130544. Danish.

PMID:
25096559
9.

Case-control study of aspirin use and risk of pancreatic cancer.

Streicher SA, Yu H, Lu L, Kidd MS, Risch HA.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1254-63. doi: 10.1158/1055-9965.EPI-13-1284.

10.

Risk of upper gastrointestinal bleeding from different drug combinations.

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC.

Gastroenterology. 2014 Oct;147(4):784-792.e9; quiz e13-4. doi: 10.1053/j.gastro.2014.06.007. Epub 2014 Jun 14.

PMID:
24937265
11.

A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: a case-crossover design.

Wu IC, Lin MY, Yu FJ, Hsieh HM, Chiu KF, Wu MT.

PLoS One. 2014 May 30;9(5):e98326. doi: 10.1371/journal.pone.0098326. eCollection 2014.

12.

Risk of upper gastrointestinal bleeding when taking SSRIs with NSAIDs or aspirin.

Kuo CY, Liao YT, Chen VC.

Am J Psychiatry. 2014 May;171(5):582. doi: 10.1176/appi.ajp.2014.14010108. No abstract available.

PMID:
24788285
13.

Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin.

Jaspers Focks J, Tielemans MM, van Rossum LG, Eikendal T, Brouwer MA, Jansen JB, Laheij RJ, Verheugt FW, van Oijen MG.

Neth Heart J. 2014 Mar;22(3):107-12. doi: 10.1007/s12471-014-0522-3.

14.

Upper gastrointestinal bleeding in elderly adults with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Thavorn K, Gomes T, Camacho X, Yao Z, Juurlink D, Mamdani M.

J Am Geriatr Soc. 2014 Feb;62(2):382-4. doi: 10.1111/jgs.12670. No abstract available.

15.

Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.

Takada M, Fujimoto M, Hosomi K.

Int J Clin Pharmacol Ther. 2014 Mar;52(3):181-91. doi: 10.5414/CP201997.

PMID:
24472400
16.

[Evaluation of drug information service available for physicians regarding low-dose aspirin-induced gastrointestinal lesions].

Suzuki Y, Yokoyama H, Soeda S, Tokuoka K, Watanabe M, Kitagawa Y, Yamada Y.

Yakugaku Zasshi. 2014;134(4):545-53. Epub 2014 Jan 18. Japanese.

17.

Novel single nucleotide polymorphism markers for low dose aspirin-associated small bowel bleeding.

Shiotani A, Murao T, Fujita Y, Fujimura Y, Sakakibara T, Nishio K, Haruma K.

PLoS One. 2013 Dec 18;8(12):e84244. doi: 10.1371/journal.pone.0084244. eCollection 2013.

18.

Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.

Lin KJ, De Caterina R, García Rodríguez LA.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):70-7. doi: 10.1161/CIRCOUTCOMES.113.000494. Epub 2013 Nov 19.

19.

Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis.

Yuhara H, Corley DA, Nakahara F, Nakajima T, Koike J, Igarashi M, Suauki T, Mine T.

J Gastroenterol. 2014 Jun;49(6):992-1000. doi: 10.1007/s00535-013-0905-z. Epub 2013 Nov 14. Review.

PMID:
24221694
20.

Role of aspirin in cancer prevention.

Thorat MA, Cuzick J.

Curr Oncol Rep. 2013 Dec;15(6):533-40. doi: 10.1007/s11912-013-0351-3. Review.

PMID:
24114189
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk